Jeffrey W. Elias, PhD UCD SOM Office of Research Grants Facilitation.
|
|
- Edward Dickerson
- 5 years ago
- Views:
Transcription
1 NIH IS CHANGING/ENHANCING THE REVIEW CRITERIA AND FOCUSING ON MISSING OPPORTUNITIES TO EXAMINE SEX DIFFERENCES JOURNALS ARE CHANGING/ENHANCING THE REVIEW CRITERIA Jeffrey W. Elias, PhD UCD SOM Office of Research Grants Facilitation
2 Sex Differences are part of Reproducibility Issues in Scientific Studies Changes in the NIH 2016 submission/review cycle 1) NIH enhances reproducibility standards for application science and review primary issues of bias in design (to include exclusion of sex differences) and bias in reporting data. 2) Focus on enhancing animal research to include sex differences 3) Journal standards for enhancing reproducibility less obvious emphasis on sex differences.
3 Sex Differences are part of Reproducibility Issues in Scientific Studies Sex refers to a set of biological attributes in humans and animals. It is primarily associated with physical and physiological features including sex chromosomes, gene expression, hormone levels and function, and reproductive/sexual anatomy. Sex is usually categorized as female or male but there is variation in the biological attributes that comprise sex and how those attributes are expressed.
4 Sex Differences are part of Reproducibility Issues in Scientific Studies Gender refers to the socially constructed roles, behaviors, expressions and identities of girls, women, boys, men, and gender diverse people. It influences how people perceive themselves and each other, how they act and interact, and the distribution of power and resources in society. Gender is usually conceptualized as a binary (girl/woman and boy/man) yet there is considerable diversity in how individuals and groups understand, experience and express it.
5 Addressing Reproducibility Issues to Include Sex Differences BIAS: From a personal perspective as a researcher, journal reviewer, study section reviewer, and journal editor the most frequent source of bias is a hypothesis: 1) hypotheses often ignore sources of variance that should be known or explored (i.e., lazy hypothesizing). We have been lazy about sex differences. 2) investigators try to fit the data to the hypotheses as proposed and do not follow the results, which is a form of biased reporting.
6 Addressing Reproducibility Issues to Include Sex Differences Funding Opportunity PA , Administrative Supplements for Research on Sex/Gender Differences The Office of Research on Women s Health (ORWH) Most institutes have signed on to PA Due March 4 non-competing administrative supplements 100K Must have 18 months remaining on parent grant
7 Addressing Reproducibility Issues to Include Sex Differences PA , Administrative Supplements for Research on Sex/Gender Differences In 1993, the NIH Revitalization Act required the inclusion of women in NIH-funded clinical research. (from supplement on sex differences) There has not been a corresponding revolution in experimental design and analyses in cell and animal research despite multiple calls to action. Publications often continue to neglect sex-based considerations and analyses in preclinical studies.
8 Addressing Reproducibility Issues to Include Sex Differences PA , Administrative Supplements for Research on Sex/Gender Differences The NIH plans to address the issue of sex and gender inclusion across biomedical research multi-dimensionally through program oversight, review and policy, as well as through collaboration with stakeholders including publishers. This move is essential, potentially very powerful and need not be difficult or costly.
9 Addressing Reproducibility Issues to Include Sex Differences M. Parikh, (2015), Subject selection bias in animal studies, Current Science, Vol. 109, No August. Stroke events are more prevalent in females compared to males, but female animals are used in only 38% of studies. Hypertension is found to be equally present in both sexes, but 65% of scientific reports have males as the study subjects. Male biases were found in 8 out of 10 biological fields.
10 Addressing Reproducibility Issues to Include Sex Differences M. Parikh, (2015), Current Science. 80% of the studies in surgical journals used male animals Women are 1.5 times more susceptible to pain than men and women show higher adverse drug reactions, but still studies use males exclusively, which resulted in withdrawal of 8 out of 10 prescription drugs from the US market as side effects manifested differently in both sexes..
11 Addressing Reproducibility Issues to Include Sex Differences Can this effort be successful? Canadian Institute of Health Research (CIHR) requires its applicants to answer mandatory questions on sex and gender; unlike the NIH, it does not mandate the inclusion of specific populations in research designs, nor does it have corresponding peer review criteria on sex and gender
12 Addressing Reproducibility Issues to Include Sex Differences Can this be successful? In recognition of the important influences of sex and gender on health, in December 2010 CIHR made a change to its grant application forms, requiring that all applicants respond to two questions: Are sex (biological) considerations taken into account in this study? Are gender (socio-cultural) considerations taken into account in this study?
13 Addressing Reproducibility Issues to Include Sex Differences Canadian Institute of Health & Research motivations for change. With ratios of male-only against female-only studies the ratios were: 5.5 in neuroscience, 5.0 in pharmacology and 3.7 in physiology. 75% articles in reputed immunology journals did not indicate the sex of animals used in the study.
14 Figure 2. Applicant by research area, competition and responses to sex and gender items. Johnson J, Sharman Z, Vissandjée B, Stewart DE (2014) Does a Change in Health Research Funding Policy Related to the Integration of Sex and Gender Have an Impact?. PLoS ONE 9(6): e doi: /journal.pone
15 Suggestions for approaching the enhancement of rigor and sex differences mandated by NIH READ: 1) NOT-OD for further consideration of NIH expectations about sex as a biological variable. 2) General FAQs from NIH found at 3)Most recent article by Clayton & Collins for tips on developing sex differences approach. Clayton, J. & Collins F. (2014), NIH to balance sex in cell and animal studies.nature, Vol. 509, 15 MAY 2014,
16 Suggestions for approaching the enhancement of rigor and sex differences mandated by NIH Read: Landis et al (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature, Oct 11;490(7419): doi: /nature11556.
17 Suggestions for approaching the enhancement of rigor and sex differences mandated by NIH Pay attention to: By November 25, 2015 application guide instructions will be updated to include the following additional guidance for. Significance Describe the scientific premise for the proposed project, including consideration of the strengths and weaknesses of published research or preliminary data crucial to the support of your application. Approach Describe the experimental design and methods proposed and how they will achieve robust and unbiased results.
18 Suggestions for approaching the enhancement of rigor and sex differences mandated by NIH Pay attention to: Using too subtle an approach to enhanced review issues But I did mention it on page 102! Make reviewers pay attention. Be clear if you are developing hypotheses (e.g., sex differences) or testing hypotheses. Don t be lazy in literature review.
19 Suggestions for approaching the enhancement of rigor and sex differences mandated by NIH Pay attention to: adding sex as a factor in statistical design. There are seven effects involved in a threeway factorial Three main effects (one for each independent variable) Three 2-way interactions One 3-way interaction
20 Suggestions for approaching the enhancement of rigor and sex differences mandated by NIH Pay attention to: adding sex as a factor in a statistical design. There are 15 effects involved in a four-way design Four main effects (one for each independent variable) Six 2-way interactions Four 3-way interactions One 4-way interaction
21 Suggestions for approaching the enhancement of rigor and sex differences mandated by NIH Pay Attention To: Major concern for NIH grants and clinical trials - the focus is on detail of methods. No additional application pages are allotted. Reviewers are refocused before the first round of reviews after January 16, Work in progress for reviewers and applicants.
22 Landis et al (2012) NINDS Nature. Author manuscript; available in PMC 2013 Apr 11. Published in final edited form as: Nature Oct 11; 490(7419): doi: /nature11556 PMCID: PMC NIHMSID: NIHMS A call for transparent reporting to optimize the predictive value of preclinical research
23 Landis Enhancing Animal Research The main workshop recommendation is that at a minimum studies should report on sample-size estimation, whether and how animals were randomized, whether investigators were blind to the treatment, and the handling of data.
24 Landis Enhancing Animal Research Standards Encourage the use of community-based standards (such as nomenclature standards and reporting standards like ARRIVE), where applicable. Replicates Require that investigators report how often each experiment was performed and whether the results were substantiated by repetition under a range of conditions. Sufficient information about sample collection must be provided to distinguish between independent biological data points and technical replicates.
25 Landis Enhancing Animal Research Core set of standards for rigorous reporting of study design (Adapted from Landis et al.) Include these reporting standards in Information for Authors or other public place. Require authors to fill out a checklist, ideally upon submission, to state where the required information is located in the manuscript.
26 Landis Enhancing Animal Research Blinding Require authors to state whether experimenters were blind to group assignment and outcome assessment, at a minimum for all animal experiments. Sample-size estimation Require authors to state whether an appropriate sample size was computed when the study was being designed and include the statistical method of computation. If no power analysis was used, include how the sample size was determined.
27 Landis Enhancing Animal Research Inclusion and exclusion criteria Require authors to clearly state the criteria that were used for exclusion of any data or subjects. Include any similar experimental results that were omitted from the reporting for any reason, especially if the results do not support the main findings of the study. Describe any outcomes or conditions that were measured or used and are not reported in the results section.
28 Landis Enhancing Animal Research Statistics Require that statistics be fully reported in the paper, including the statistical test used, exact value of N, definition of center, dispersion and precision measures (e.g., mean, median, SD, SEM, confidence intervals) Randomization Require authors to state whether the samples were randomized and specify method of randomization, at a minimum for all animal experiments.
29 Reproducibility Journal Standards Journals should have no limit or generous limits on the length of methods sections (including online options), while at the same time encouraging efficient and clear presentation to ensure a thorough examination by reviewers. Journals should use a checklist during editorial processing to ensure the reporting of key methodological and analytical information to reviewers and readers. (A proposed set of key information is listed below).
30 Reproducibility: Proposed Journal Standards Rigorous statistical analysis A section outlining the journal s policies for statistical analysis should be included in the Information for Authors, and the journal should have a mechanism to check the statistical accuracy of submissions.
31 Reproducibility Journal Standards Data and material sharing Stipulate, at the minimum, that all datasets on which the conclusions of the paper rely must be made available upon request (where ethically appropriate) during consideration of the manuscript (by editors and reviewers) and upon reasonable request immediately upon publication. Recommend deposition of datasets in public repositories, where available. Datasets in repositories should be bidirectionally linked to the published article in a way that ensures proper attribution of data production.
32 Reproducibility Journal Standards Encourage presentation of all other data values in machine readable format in the paper or its supplementary information. Require materials sharing after publication. Encourage sharing of software and require at the minimum a statement in the manuscript describing if software is available and how it can be obtained.
33 Reproducibility Journal Standards Consideration of refutations Have a policy stating that if the journal publishes a paper, it assumes responsibility to consider publication of refutations of that paper, according to its usual standards of quality.
34 Reproducibility Journal Standards Consider establishing best practice guidelines for: Image based data (image screening for manipulation, Western blots, for example) Description of biological material with enough information to uniquely identify the reagents (for example unique accession number in repository), in particular for: antibodies: also report source, characteristics, dilutions and how they were validated cell lines: also report source, authentication and mycoplasma contamination status animals: also report source, species, strain, sex, age, husbandry, inbred and strain characteristics of transgenic animals
35 Reproducibility Journal Standards antibodies: also report source, characteristics, dilutions and how they were validated cell lines: also report source, authentication and mycoplasma contamination status animals: also report source, species, strain, sex, age, husbandry, inbred and strain characteristics of transgenic animals
RIGOR AND REPRODUCIBILITY: BACK TO BASICS
RIGOR AND REPRODUCIBILITY: BACK TO BASICS OCT 27, 2016 NIH REGIONAL SEMINAR - CHICAGO OVERVIEW Why the concern about reproducibility? The NIH response Updates to grant applications Training and Resources
More informationTHE NIH PERSPECTIVE ON RIGOR AND REPRODUCIBILITY
THE NIH PERSPECTIVE ON RIGOR AND REPRODUCIBILITY MAY 30, 2017 PATRICIA VALDEZ, PhD NIH EXTRAMURAL RESEARCH INTEGRITY OFFICER Office of Extramural Programs Nature, 25 May 2016 2 The Reproducibility Challenge
More informationNew NIH 2-page Rigor and Transparency Document
New NIH 2-page Rigor and Transparency Document Grants affected in 2016 include: NOT-OD-16-081 NOT-OD-16-058 NOT-OD-16-034 NOT-OD-16-011 NOT-OD-16-031 NOT-OD-16-012 NOT-OD-16-005 NOT-OD-16-004 NOT-OD-15-103
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: RuRong Ji NNA59063A Article Reporting Checklist for Nature Neuroscience # Main ures: 8 # Supplementary ures: 15 # Supplementary Tables: 0 # Supplementary
More informationPractical What & Where of Rigor and Reproducibility in the NIH Application. SIU School of Medicine Office of Grants & Contracts with Sophia Ran, PhD
Practical What & Where of Rigor and Reproducibility in the NIH Application SIU School of Medicine Office of Grants & Contracts with Sophia Ran, PhD Recent Training Sessions NIH Regional Seminar Rigor and
More informationNew NIH Expectations: Are You Ready? David T. Redden, PhD Co-Director, CCTS BERD Chair, Department of Biostatistics
New NIH Expectations: Are You Ready? David T. Redden, PhD Co-Director, CCTS BERD Chair, Department of Biostatistics NIH Proposed Action Training emphasizing good experimental design. Checklist for analytic
More informationNew Year, New NIH Expectations: Are You Ready?
New Year, New NIH Expectations: Are You Ready? Jennifer A. Croker, PhD Admin. Director, CCTS Research Commons David T. Redden, PhD Co-Director, CCTS BERD Chair, Department of Biostatistics December 2,
More informationEfforts to Improve Data Transparency at the JBC
Efforts to Improve Data Transparency at the JBC Roger J. Colbran Associate Editor Credit: Amanda Fosang, Associate Editor 2 Why Improve Transparency? Irreproducibility of pre-clinical studies Negative
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Marcelo Coba Manuscript Number: NNRS3314D Manuscript Type: Resource Reporting Checklist for Nature Neuroscience # Main Figures: 7 # lementary Figures: 4 # lementary Tables: 11 # lementary
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Chay T. Kuo NNA47008 Article Reporting Checklist for Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 11 # Supplementary Tables:
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Michael Cole NNA51 Article Reporting Checklist for Nature Neuroscience # Main Figures: 5 # lementary Figures: 4 # lementary Tables: 0 # lementary
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Leonard Petrucelli NNA52530C Article Reporting Checklist for Nature Neuroscience # Main s: 8 # Supplementary s: 10 # Supplementary Tables: 3 #
More informationPROMOTING TRANSPARENT RESEARCH METHODS, PROTOCOLS AND DATA TO REDUCE IRREPRODUCIBILITY
PROMOTING TRANSPARENT RESEARCH METHODS, PROTOCOLS AND DATA TO REDUCE IRREPRODUCIBILITY December 2015 STM Innovations Seminar Andrew L Hufton, PhD Managing Editor, Scientific Data Nature Publishing Group
More informationLife Sciences Reporting Summary
Life Sciences Reporting Summary Corresponding author(s): Rich, Jeremy N. Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish.
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: xiangdong fu, yuanchao xue NNA52804A Article Reporting Checklist Nature Neuroscience # Main Figures: 5 # Supplementary Figures: 7 # Supplementary
More informationImproving the design and reporting of animal studies, tools: ARRIVE Guidelines, EDA and SyRF
Improving the design and reporting of animal studies, tools: ARRIVE Guidelines, EDA and SyRF Dr Nathalie Percie du Sert Information Meeting for Grant Applicants on the Call for Proposals for Confirmatory
More informationEnhancing Reproducibility and Transparency of Research Findings
Enhancing Reproducibility and Transparency of Research Findings Reproducibility and Reliability of Biomedical Research Symposium April 2, 2015 Lawrence A. Tabak, DDS, PhD Principal Deputy Director, NIH
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: McColl NNRS50586AZ Resource Reporting Checklist for Nature Neuroscience # Main Figures: 8 # lementary Figures: 7 # lementary Tables: 13 # lementary
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Feltri NNA54268B Article Reporting Checklist for Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 5 # Supplementary Tables: 1 # Supplementary
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Yang Dan NNA56598 Article Reporting Checklist for Nature Neuroscience # Main Figures: 8 # Supplementary Figures: 12 # Supplementary Tables: 0 #
More informationAnimal Issues in Research Reproducibility
Animal Issues in Research Reproducibility Gaylen L. Edwards, DVM, PhD Animal Care and Experimentation Committee American Physiological Society College of Veterinary Medicine University of Georgia Why Should
More informationUpdate: Enhancing Rigor and Reproducibility of Research Findings
Update: Enhancing Rigor and Reproducibility of Research Findings Advisory Committee to the Director (ACD) December 12 th, 2014 Lawrence A. Tabak, DDS, PhD Deputy Director, NIH Department of Health and
More informationArchives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections
(Based on APA Journal Article Reporting Standards JARS Questionnaire) 1 Archives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections JARS: ALL: These questions
More informationTOPICS TOPICS. Navigating NIH 2016 Policy Changes for Grant Applications and Availability of Proposal Resources
Navigating NIH 2016 Policy Changes for Grant Applications and Availability of Proposal Resources John Ivy, Ph.D. Sr. Research Development Officer johnivy@tamu.edu Christina Papke, Ph.D. Research Development
More informationLife Sciences Reporting Summary
Life Sciences Reporting Summary Adams Waldorf, Rajagopal, Gale Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish. This
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Liu NNA52890T Article Reporting Checklist for Nature Neuroscience # Main Figures: 4 # Supplementary Figures: 3 # Supplementary Tables: 1 # Supplementary
More informationGSP revisited: Increasing Value, Reducing Waste. Daniel Strech, MD, PhD
GSP revisited: Increasing Value, Reducing Waste Daniel Strech, MD, PhD Standard GSP Recommendations Plan carefully! Get ethics review! Do not manipulate, lie, or plagiate! Document and store appropriately!
More informationAnalyzing the Scientific Literature: Pitfalls and Reproducibility
Analyzing the Scientific Literature: Pitfalls and Reproducibility Samuel M. Cohen, M.D., Ph.D. Department of Pathology and Microbiology University of Nebraska Medical Center Omaha, NE 68198-3135, USA scohen@unmc.edu
More informationNavigating the new NIH Guidelines on Rigor and Reproducibility (Transparency) Gary W. Miller, PhD
Navigating the new NIH Guidelines on Rigor and Reproducibility (Transparency) Gary W. Miller, PhD April 21, 2016 RR101 If you oppose the spirit of this initiative then you are in the wrong field NIH s
More informationEdinburgh Research Explorer
Edinburgh Research Explorer Protocol for a retrospective, controlled cohort study of the impact of a change in Nature journals' editorial policy for life sciences research on the completeness of reporting
More informationEditor-in-Chief, 23rd March 2017
Author s response to reviews Title: Single Use and Conventional Bronchoscopes for Broncho alveolar Lavage (BAL) in research: A comparative study (NCT 02515591) Authors: Seher Raza Zaidi (seher.zaidi@lstmed.ac.uk)
More information8/2/2017. Key attributes of scientific excellence: rigor, innovation, and relevance. Medical Physics 3.0. Key Attributes of Scientific Excellence
Medical Physics 3.0 in Design Key attributes of scientific excellence: rigor, innovation, and relevance Maryellen Giger, Ph.D. A. N. Pritzker Professor of Radiology / Medical Physics The University of
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Robert Froemke NNA7412T Article Reporting Checklist for Nature Neuroscience # Main s: 7 # Supplementary s: 14 # Supplementary Tables: 0 # Supplementary
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Rachel Wilson NNA48246B Article Reporting Checklist for Nature Neuroscience # Main Figures: 8 # Supplementary Figures: 7 # Supplementary Tables:
More informationRobustness of Academic Data
Robustness of Academic Data Daria Mochly-Rosen This lecture is based on and includes citations from 1. Peers et al., Nature Reviews Drug Discovery 11:733, 2012 2. Prinz et al., Nature Reviews Drug Discovery,
More informationReporting Checklist for Nature Neuroscience
Corponding Author: Manuscript Number: Manuscript Type: Gregory C. DeAngelis NNA49009A Article Reporting Checklist for Nature Neuroscience # Main Figu: 7 # lementary Figu: # lementary Tables: 0 # lementary
More informationModule 1 BACKGROUND GENDER AND FEMALE TALENT
Module 1 BACKGROUND GENDER AND FEMALE TALENT Session 1 Gender and female talent a conceptual framework Gender biases are inaccurate and false generalizations that color our assumptions and expectations
More informationTechnical Guidance on Development of In Vitro Companion Diagnostics and Corresponding Therapeutic Products
Administrative Notice December 26, 2013 To: Division of Pharmaceutical Affairs, Prefectural Health Department (Bureau) From: Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry
More informationAre You Aware of New Publication Guidelines?
Are You Aware of New Publication Guidelines? The application of rigor ensures robust and unbiased experimental design, methodology, analysis, interpretation, and reporting of results. National Institutes
More informationKathy O Kane Kreutzer, M.Ed., Office of Faculty Affairs, School of Medicine March, 2017
SOM Authorship Guidelines, Recent Updates to the ICMJE Uniform Requirements for Scholarship, and the Emerging Role of Social Media in Monitoring Scholarship Kathy O Kane Kreutzer, M.Ed., Office of Faculty
More informationAthena SWAN Gender Equity Survey 2017: Report of Results
Athena SWAN Gender Equity Survey 2017: Report of Results 1. Background As part of its commitment to gender equity and diversity more broadly the University conducted the Athena SWANi Gender Equity surveyii
More informationNational Institutes of Health (NIH) Ruth L. Kirschstein NRSA Individual Postdoctoral Fellowship (F32) PA
Agency Program Project period Budget Due date(s) National Institutes of Health (NIH) Ruth L. Kirschstein NRSA Individual Postdoctoral Fellowship (F32) PA-18-670 3 years (not renewable) NIH Postdoc Stipend
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: David Dupret NNBC5329A Brief Communication Reporting Checklist for Nature Neuroscience # s: 3 # s: 11 # Tables: 0 # Videos: 0 This checklist is
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION DOI: 10.1038/ncb3575 In the format provided by the authors and unedited. Supplementary Figure 1 Validation of key reagents and assays a, top, IHC with antibody recognizing specifically
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Lennart Mucke NNRS49607AZ Resource Reporting Checklist for Nature Neuroscience # Main s: # lementary s: 4 # lementary Tables: 9 # lementary Videos:
More informationWork to be Done vs. Animal Welfare
Research Animal Facilities 14th Transgenic Technology Meeting, TT2017 Work to be Done vs. Animal Welfare Boris Jerchow, PhD MY EXPERIENCE Basic Research Transgenic Service AWO Facility Director ANIMAL
More information2014 CLINICAL POLICY UNIT. Dr Vesna Kupresan
2014 CLINICAL POLICY UNIT Dr Vesna Kupresan Healthcare Industry Challenges Medical inflation Cost drivers Aging population Increased utilization of healthcare Growing chronic disease burden Rapid evolution
More informationfact sheet 3 Introduction to Biosimilars & Regulatory Requirements
3 fact sheet 3 Introduction to Biosimilars & Regulatory Requirements International Alliance of Patients Organizations CAN Mezzanine 49-51 East Road London N1 6AH United Kingdom International Federation
More informationsignificant concerns no or very low predictive power
Your feedback Citizens concerns should be considered How to ensure ethical concerns are harnessed to drive change? Don t separate Non-animal and animal approaches they are integrated Avoid overstating
More informationScientific journal editor core competencies
Scientific journal editor core competencies My disclosures Founding editor-in-chief, Systematic Reviews On the editorial board of several biomedical journals BMC Medicine Advisory member International
More informationSurvey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals
Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals Carol Kilkenny 1 *, Nick Parsons 2, Ed Kadyszewski 3, Michael F. W. Festing 4, Innes C. Cuthill
More informationREPLICATION STUDIES. Improving reproducibility in the empirical sciences
REPLICATION STUDIES Improving reproducibility in the empirical sciences 2 BACKGROUND Scientific progress requires research studies to be conducted rigorously, so that when they are repeated their results
More informationSex as an important biological variable in biomedical research
BMB Reports BMB Rep. 2018; 51(4): 167-173 www.bmbreports.org Invited Mini Review * Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea Experimental
More informationNINDS/HEAL Biomarker Programs New Biomarker Initiatives at NIH: Neurological Disorders and Pain
NINDS/HEAL Biomarker Programs New Biomarker Initiatives at NIH: Neurological Disorders and Pain OCTOBER 30, 2018 Mary Ann Pelleymounter, PhD Program Director mary.pelleymounter@nih.gov 1 About the Speaker
More informationCrowe Critical Appraisal Tool (CCAT) User Guide
Crowe Critical Appraisal Tool (CCAT) User Guide Version 1.4 (19 November 2013) Use with the CCAT Form version 1.4 only Michael Crowe, PhD michael.crowe@my.jcu.edu.au This work is licensed under the Creative
More informationHOW TO MAINTAIN &POPULATE THE PHS HUMAN SUBJECTS AND CLINICAL TRIALS INFORMATION FORM (HSCT 1.0) IN KC PROPOSALS
KC Proposal Instructions for populating the PHS Human Subjects and Clinical Trial Information Form 1.0 Quick Reference Card HOW TO MAINTAIN &POPULATE THE PHS HUMAN SUBJECTS AND CLINICAL TRIALS INFORMATION
More informationOpen Data Open Access to Scientific Data
Open Data Open Access to Scientific Data The perspective of a researcher Prof. Dr. Tom Coenye Tom.Coenye@UGent.be Open Data Shared Data Not necessarily the same! Data deposition (open/shared) Data available
More informationTranslational Research - Bench to Trial
TRANSLATION BENCH TRIAL Translational Research - Bench to Trial Marc T. Avey Canadian Institutes of Health Research (Knowledge Translation) Post-doctoral Fellow Clinical Epidemiology Program Ottawa Hospital
More informationEstoril Education Day
Estoril Education Day -Experimental design in Proteomics October 23rd, 2010 Peter James Note Taking All the Powerpoint slides from the Talks are available for download from: http://www.immun.lth.se/education/
More informationReporting Checklist for Nature Neuroscience
Corresponding Author: Manuscript Number: Manuscript Type: Hillel Adesnik NNA58169T Article Reporting Checklist for Nature Neuroscience # Main ures: 5 # lementary ures: 6 # lementary Tables: 1 # lementary
More informationDevelopment and Implications of a Redacted Clinical Trial Protocol for Posting Online With the Published Manuscripts
Development and Implications of a Redacted Clinical Trial Protocol for Posting Online With the Published Manuscripts Namit Ghildyal, Yvette Ng, Craig Tendler, Chris H. Takimoto, Susan Glasser Janssen Research
More informationTipping and Service: The Case of Hotel Bellmen
Cornell University School of Hotel Administration The Scholarly Commons Articles and Chapters School of Hotel Administration Collection 9-2001 Tipping and Service: The Case of Hotel Bellmen Michael Lynn
More informationLife Sciences Reporting Summary
Life Sciences Reporting Summary Corresponding author(s): Stein Aerts Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish.
More informationHow is trial registration affecting gjournals?
How is trial registration affecting gjournals? Dr Trish Groves Deputy editor, BMJ & Editor in chief, BMJ Open My competing interests Roles at BMJ contributing to, publicising, and leading implementation
More informationWhen the Door Is Closed: An Observational Study of Medical Journal Dispositions Regarding Industry Collaborations
When the Door Is Closed: An Observational Study of Medical Journal Dispositions Regarding Industry Collaborations Frimpter J 1, Beauregard M 1, Suh C 1, Huang T 2, Weigel A 3 1 US Medical Affairs, sanofi-aventis
More informationCIHR s Equity Strategy
CIHR s Equity Strategy Nicola Lauzon Senior Advisor, Science Strategy University Delegates May 4, 2017 CIHR s Equity Strategy Vision To create an equitable funding system by identifying and eliminating
More information4.3 Qualification Expertise (Canada)
L1 4.3 Qualification Expertise (Canada) Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager, Clinical Group I Office of Clinical Trials
More informationConsorted approaches to facilitate data quality, robustness and relevance in preclinical research and development
Consorted approaches to facilitate data quality, robustness and relevance in preclinical research and development Thomas Steckler The views expressed in this presentation are solely those of the individual
More information31 st March 2018 GENDER PAY GAP REPORT
31 st March 2018 GENDER PAY GAP REPORT 2017-18 Introduction 3 Data summary 4 Understanding our gap 6 Taking action 7 2 Introduction In April 2017, the Government introduced new gender pay gap ( GPG ) transparency
More informationGender Pay Gap Report 2017
Gender Pay Gap Report 2017 Introduction The College is required by law to carry out Gender Pay Reporting under the specific duties of the Equality Act 2010 (Gender Pay Gap Information) Regulations 2017.
More information5-15 Hours Practicum Credit DCS NEW Practicum: Research Project 5 N/A required
UTSW Graduate School of Biomedical Sciences Division of Clincal Science Required Courses for Non-Scholar Graduate Certificate in Clinical Science Effective Fall 2014 18 Credit Hours 2 Years Maximum Fellows
More informationEXPERT COLLECTION. Explore our leading medical review series
EXPERT COLLECTION Explore our leading medical review series Introducing the EXPERT COLLECTION The Taylor & Francis Expert Collection is the world s largest series of review journals in research, development,
More information1201 Maryland Avenue SW, Suite 900, Washington, DC ,
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org June 6, 2008 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville, MD
More informationAn Introduction to Clinical Research and Development
Bay Clinical R&D Services An Introduction to Clinical Research and Development The Complex Process by which New Drugs are Tested in Humans Anastassios D. Retzios, Ph.D. Outline of Presentation What is
More informationISO 13528:2015 Statistical methods for use in proficiency testing by interlaboratory comparison
ISO 13528:2015 Statistical methods for use in proficiency testing by interlaboratory comparison ema training workshop August 8-9, 2016 Mexico City Class Schedule Monday, 8 August Types of PT of interest
More informationMethods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) SYNOPSIS
B Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) elow is the format to follow for the concept sheet for protocols. It is based on the International Committee
More informationNOTICE. Subject: Stakeholders suggestions/comments on Clinical Trials conductance in India
NOTICE Dated: 28.07.2014 Subject: Stakeholders suggestions/comments on Clinical Trials conductance in India During the briefing on CDSCO, Hon ble Minister of Health & Family Welfare desired that there
More informationDEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS
11TH ANNUAL MEETING OF ISMPP DEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS April 28, 2015 Hyatt Regency Crystal City Arlington, VA, USA 11TH ANNUAL
More informationImportant Information for MCP Authors
Guidelines to Authors for Publication of Manuscripts Describing Development and Application of Targeted Mass Spectrometry Measurements of Peptides and Proteins and Submission Checklist The following Guidelines
More informationOvercoming Statistical Challenges to the Reuse of Data within the Mini-Sentinel Distributed Database
September 5, 2012 September 5, 2012 Meeting Summary Overcoming Statistical Challenges to the Reuse of Data within the Mini-Sentinel Distributed Database With passage of the Food and Drug Administration
More informationINSTRUCTIONS FOR COMPLETION OF THE CCAC ANIMAL USE DATA FORM
INSTRUCTIONS FOR COMPLETION THE CCAC ANIMAL USE DATA FORM TABLE CONTENTS 1. PREAMBLE... 1 2. INTRODUCTION... 1 3. TO BE INCLUDED ON THE AUDF... 2 4. REQUIRED ELEMENTS... 2 1. Unique Protocol Number...
More informationAims and challenges of clinical trial data sharing
Aims and challenges of clinical trial data sharing Facilitating data access to non-industry funded research UCL and Yale meeting: 9 October 2015 London Dr Trish Groves Head of research,
More informationA number of studies have documented lower levels of schooling or formal education in
1. Introduction A number of studies have documented lower levels of schooling or formal education in developing countries among females relative to males (see for example, Dollar and Gatti 1999; Duflo
More informationHow to write and publish a paper
How to write and publish a paper December 2018 Adrian Aldcroft, Editor in Chief, BMJ Open Writing research papers and using reporting guidelines Resources IMRaD Writing style Research to Publication rtop.bmj.com
More informationFacilitating Antibacterial Drug Development: Bayesian vs Frequentist Methods
Facilitating Antibacterial Drug Development: Bayesian vs Frequentist Methods Scott S. Emerson, M.D., Ph.D. Professor of Biostatistics University of Washington The Brookings Institution May 9, 2010 First:
More informationDraft agreed by Scientific Advice Working Party 5 September Adopted by CHMP for release for consultation 19 September
23 January 2014 EMA/CHMP/SAWP/757052/2013 Committee for Medicinal Products for Human Use (CHMP) Qualification Opinion of MCP-Mod as an efficient statistical methodology for model-based design and analysis
More informationNavigating the NIH Public Access Policy. Carson Harrod, PhD Assistant Investigator Baylor Scott & White Research Institute, Dallas, TX, USA
Navigating the NIH Public Access Policy Carson Harrod, PhD Assistant Investigator Baylor Scott & White Research Institute, Dallas, TX, USA Acknowledgements Some of these slides were modified from an NIH
More informationTowards Greater International Transparency of Clinical Trials
Karmela Krleza-Jeric,MD, M.Sc., D.Sc. CIHR - IRSC Towards Greater International Transparency of Clinical Trials Short Term Efforts for Long Term Benefits: CIHR trial policy 2010 1 Outline Prospective trial
More informationMeasuring Capacity and Effectiveness of NIH Public Access Policy Programming as a Model for Open Access
University of New Mexico UNM Digital Repository Evidence Based Scholarly Communications Conference HSLIC Events 7-24-2010 Measuring Capacity and Effectiveness of NIH Public Access Policy Programming as
More informationImpact Evaluation. Some Highlights from The Toolkit For The Evaluation of Financial Capability Programs in LMIC
Impact Evaluation Some Highlights from The Toolkit For The Evaluation of Financial Capability Programs in LMIC World Bank Dissemination Workshop, New Delhi March 2013 What is the Toolkit? Russia Trust
More informationUK Gender Pay Gap Report 2017
UK Gender Pay Gap Report 2017 Building a diverse and inclusive workplace in which everyone is compensated fairly is incredibly important to us. Our UK Gender Pay Gap report shows that we need to get more
More informationPublished on The YODA Project (
Principal Investigator First Name: Mirjana Last Name: Stanic Benic Degree: MD Primary Affiliation: UHC Rijeka E-mail: mirji.stanic@gmail.com Phone number: 00385992367664 Address: Kresimirova 42e Kresimirova
More informationIsidro B. Salusky, MD
Isidro B. Salusky, MD Distinguished Professor of Pediatrics Division Chief, Pediatric Nephrology Director, Clinical Translational Research Center Associate Dean for Clinical Research David Geffen School
More informationSubgroups along the development axis
Paper PD03 A dedicated Programming Group working in a pharmaceutical Modeling & Simulation organization Vincent Buchheit, Novartis, Basel, Switzerland 1. ABSTRACT Modeling and Simulation (M&S) emerges
More informationMunafò, M. R. (2016). Opening up addiction science. Addiction, 111(3), DOI: /add.13147
Munafò, M. R. (2016). Opening up addiction science. Addiction, 111(3), 387 388. DOI: 10.1111/add.13147 Peer reviewed version Link to published version (if available): 10.1111/add.13147 Link to publication
More informationCanadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines
Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines 1. Introduction The Canadian Cancer Clinical Trials Network (3CTN) will support a portfolio of academic clinical trials
More informationWhole Animal Experiments Should Be More Like Human Randomized Controlled Trials
Perspective Whole Animal Experiments Should Be More Like Human Randomized Controlled Trials Beverly S. Muhlhausler 1 *, Frank H. Bloomfield 2,3,4, Matthew W. Gillman 5,6 1 FOODplus Research Centre, School
More informationIntroduction to the FDA. Historical Context. Changes over Time FDA - BE-200 9/23/2004. Copyright C. S. Tritt, Ph.D. 1
Introduction to the FDA C. S. Tritt, Ph.D. October 21, 2003 Historical Context In the early 1900 s people were being ripped off, made sick and even killed by bad food, patent medicines and cosmetics with
More informationArchives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections
(Based on APA Journal Article Reporting Standards JARS Questionnaire) 1 Archives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections JARS: ALL: These questions
More informationClinicalTrials.gov Updates. Gabrielle Gaspard Assistant Director Human Research Compliance
ClinicalTrials.gov Updates Gabrielle Gaspard Assistant Director Human Research Compliance 02.12.18 1 Posting Requirements for ClinicalTrials.gov Reporting Requirement ICMJE Policy (effective in 2005) FDAAA
More information